Point72 Asset Management
SGMO

Point72 Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Point72 Asset Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-750,000
Closed -$492K – 2560
2025
Q1 		$492K Buy
+750,000
New +$794K ﹤0.01% 1633
2018
Q3 		– Sell
-250,000
Closed -$3.55M – 1201
2018
Q2 		$3.55M Buy
+250,000
New +$4.15M 0.01% 677
2014
Q4 		– Sell
-488,400
Closed -$5.27M – 786
2014
Q3 		$5.27M Buy
+488,400
New +$6.38M 0.04% 394

Other funds holding SGMO

YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Point72 Asset Management's SGMO Position: Q2 2025 in Review

Point72 Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2025, closing a stake of 1,998,043 shares — an estimated $1.31M sold.

Point72 Asset Management first reported a position in SGMO in Q2 2014 and held it in 15 quarters. The position peaked at $12M in Q2 2014. 114 funds tracked by Wall St. Rank hold SGMO as of Q2 2025.

  • Point72 Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2025 after selling out during the quarter.
  • Point72 Asset Management sold 1,998,043 SANGAMO THERAPEUTICS INC shares in Q2 2025, an estimated $1.31M.
  • Point72 Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and held it in 15 quarters.
  • Point72 Asset Management's SANGAMO THERAPEUTICS INC position peaked at $12M in Q2 2014.
  • 114 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2025.

Based on Point72 Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.